Maven Securities LTD Immatics N.V. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.58 - $15.46 $1.17 Million - $1.57 Million	-101,245 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.43 - $12.81 $84,483 - $103,761	8,100 Added 8.7%	101,245 $1.18 Million
Q1 2021 May 17, 2021	BUY	$10.24 - $14.6 $953,804 - $1.36 Million	93,145 New	93,145 $1.04 Million
Q4 2020 Feb 12, 2021	SELL	$9.67 - $12.05 $589,376 - $734,435	-60,949 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$8.73 - $15.15 $532,084 - $923,377	60,949 New	60,949 $647,000

68.8M

507K

170K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $895M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.